Metabolic effects of androgen deprivation therapy - Wikidata - wikimedia - TriplyDB

Metabolic effects of androgen deprivation therapy

Metabolic effects of androgen deprivation therapy

http://www.wikidata.org/entity/Q34962416

about

Metabolomic profiling of hormone-dependent cancers: a bird's eye view Erectile Dysfunction and Low Sex Drive in Men with Type 2 DM: The Potential Role of Diabetic Pharmacotherapy.Androgens and Hypertension in Men and Women: a Unifying View.

P2860

Q28084834-3A247FD9-8224-4ED1-B705-76471587C312 Q37630017-D294713B-96AE-4F03-9F32-4FC07E28C6E9 Q38813324-2B066874-E1FE-406A-BD35-EC37FBBEC197

P2860

Metabolic effects of androgen deprivation therapy

http://www.wikidata.org/entity/Q34962416

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Metabolic effects of androgen deprivation therapy

@ast

Metabolic effects of androgen deprivation therapy

@en

Metabolic effects of androgen deprivation therapy

@nl

type

label

Metabolic effects of androgen deprivation therapy

@ast

Metabolic effects of androgen deprivation therapy

@en

Metabolic effects of androgen deprivation therapy

@nl

prefLabel

Metabolic effects of androgen deprivation therapy

@ast

Metabolic effects of androgen deprivation therapy

@en

Metabolic effects of androgen deprivation therapy

@nl

P1433

Q34962416-6F4B5D99-2143-4B29-B38C-AB502107BE08

P1476

Q34962416-B9AED110-2AFE-4206-8175-6394B9725C2E

P2093

Q34962416-14F77BC3-8DC8-4265-88BC-983FFB06D6AF

P275

Q34962416-C9ACE314-A30A-467F-A069-CF8C25C5F305

P2860

Q34962416-0AA4AF60-E1F0-465F-A7CA-5FD2250DB3F5

Q34962416-0F2EE749-1EFE-4DAD-9972-606277F3E67B

Q34962416-1045DBB8-7038-4864-BF7A-1A235C29B5F0

Q34962416-13660E9E-6B21-4035-AA11-D66C23BE8B8F

Q34962416-13A00B59-54E7-40E5-BB1C-E56FBDB79B1E

Q34962416-182C6B45-8A56-4F6C-86C4-40B403D48DA2

Q34962416-2336D0C6-5488-4864-A6CD-B1363F5EC392

Q34962416-2B28F320-CCA6-4E7C-9377-A77D801A5FED

Q34962416-2E9024D7-B50A-40DF-8424-E0CC6116A9B0

Q34962416-2ED72A62-EFF8-4BC7-8A7C-5699795E87D6

P304

Q34962416-86AA843F-A14E-479C-9A81-6ECBE1478EA7

P31

Q34962416-1D82B2A2-D936-43FC-9175-5BC1A8A4BD1D

P356

Q34962416-04F59256-8B2D-408A-812A-DF083D995E85

P433

Q34962416-265F91CC-8A02-4431-9879-9288D8DD88A7

P478

Q34962416-DE7DCF42-ECB1-4F02-AF0B-13D1447AEC21

P50

Q34962416-2764F82C-F62D-4888-B0E1-6B6D2407124D

P5008

Q34962416-03EF392F-853D-4248-A3F7-74EB71A49083

P577

Q34962416-E1E4BEDD-C889-41A6-AFF4-8731EFF34CDD

P5875

Q34962416-FADB04FB-D2CA-4C68-B41D-6EA6129B832F

P698

Q34962416-254FB533-0EA3-489C-BD8F-9E1C2AE89FFB

P921

Q34962416-2E7BEC0A-6CC5-46FD-AF4B-11E7C05511A8

Q34962416-658CBEF0-95BB-48E3-8DC0-10D58E3E17A4

Q34962416-936EE2ED-C64E-4D39-85A1-B4CD6BB3A2D8

Q34962416-A220E11B-0C0A-420C-B374-900EB2329983

Q34962416-B7AD4E51-3190-490B-9CE1-20592E15A798

P932

Q34962416-BF3D7CBC-4CB5-44AF-A35A-1FC4D0590E80

P356

KJU.2015.56.1.12

P1433

Korean journal of urology

P1476

Metabolic effects of androgen deprivation therapy

@en

P2093

Sung Chul Kam

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

Global cancer statistics

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

Testosterone, body composition and aging.

Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome.

Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.

Cardiovascular risk during hormonal treatment in patients with prostate cancer.

P304

12-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4111/KJU.2015.56.1.12

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2015-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271219672

http://www.w3.org/2001/XMLSchema#string

P698

25598932

http://www.w3.org/2001/XMLSchema#string

P921

hormone antagonist

prostate cancer

nerve tissue proteins

P932

4294850

http://www.w3.org/2001/XMLSchema#string